AngioDynamics (NASDAQ:ANGO) announced on January 31 its intention to acquire competitor Navilyst Medical for $372 million in cash and stock. Navilyst Medical owners Avista Capital Partners acquired the company from Boston Scientific in 2008. Navilyst’s revenues in 2011 were approximately $149 million. Both AngioDynamics and Navilyst Medical service the peripheral vascular market.

AngioDynamics expects combined revenues of $360 million in FY2013 with $60 million EBITDA.

Comments are closed.